facebook

Does the clinic have access to laser eye surgery for enhancement if needed?

3 min read

A proportion of patients will have residual refractive error following ICL implantation. This is not a failure – it reflects the natural limits of lens power calculation in individual eyes, minor sizing variability, and in some cases the presence of pre-existing corneal irregularity that is incompletely corrected by the implant alone. Enhancement by laser eye surgery applied to the corneal surface above an in-situ ICL is a well-established and effective strategy for addressing residual ametropia. ¹ ²

The clinical question that flows from this is straightforward: does the centre performing your ICL surgery have in-house laser capability, or would enhancement require referral elsewhere? The distinction matters because continuity of clinical responsibility is not a convenience – it is a safety parameter. A different surgeon, at a different centre, who has not seen the pre-operative biometry, the operative notes, or the post-operative vault measurements is operating with incomplete information when making enhancement decisions. ³

At Blue Fin Vision®, the same consultant who performs ICL surgery also performs any subsequent laser enhancement. The pre-operative dataset – corneal topography, ECC, anterior chamber measurements, and refractive history – remains within the same clinical record. Enhancement decisions are made by the surgeon who has complete knowledge of the eye, not by a colleague working from a referral letter. In-house laser capability is not a feature to be advertised – it is a clinical standard that ICL patients should require.

References

  1. Ganesh S, Brar S. Clinical outcomes of phakic intraocular lens implantation for the correction of high myopia with three years of follow-up. Clin Ophthalmol. 2013;7:2011–2021. PMID: 24204123.
  2. Packer M. Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens. Clin Ophthalmol. 2016;10:1059–1077. PMID: 27390517.
  3. Fernandes P, González-Méijome JM, Madrid-Costa D, Ferrer-Blasco T, Jorge J, Montés-Micó R. Implantable collamer posterior chamber intraocular lenses: a review of potential complications. J Refract Surg. 2011;27(10):765–776. PMID: 21610721.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.